• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童或青少年时期家族成员死亡与随后物质使用障碍之间的关联:系统评价和荟萃分析。

The association between familial death in childhood or adolescence and subsequent substance use disorder: A systematic review and meta-analysis.

机构信息

School of Medicine, Royal College of Surgeons in Ireland, Ireland.

Department of Psychiatry, Royal College of Surgeons in Ireland, Ireland; Department of Psychology, Royal College of Surgeons in Ireland, Ireland.

出版信息

Addict Behav. 2021 Sep;120:106936. doi: 10.1016/j.addbeh.2021.106936. Epub 2021 Mar 26.

DOI:10.1016/j.addbeh.2021.106936
PMID:33975176
Abstract

BACKGROUND

Exposure to childhood adversity has been linked to long-term negative mental health consequences in adulthood.

PURPOSE

This review examined the association between exposure to the death of a family member (i.e., parent or sibling) during childhood or adolescence and the subsequent diagnosis of a substance use disorder.

METHODS

Electronic databases (Scopus, Medline (for Ovid), EMBASE, and PsychINFO) were searched for cohort and case-control studies in the English language. Studies were retained if it was demonstrable that exposure to death occurred before age 18, and that disorder was diagnosed subsequently. Sensitivity analyses were performed for the meta-analysis, and study quality assessed using the Newcastle-Ottawa Scale.

RESULTS

Nine studies, seven cohort and two case-control, were retained. Due to differential metrics (hazard ratios [HRs] versus odds/risk ratios [ORs/RRs]), only one meta-analysis was possible. Individuals experiencing familial death had 1.42 (95% CI = 0.96, 2.09) times the odds of developing a substance use disorder compared to those non-exposed. Where there was a statistically significant effect in other studies, these were mostly studies using National Registers (1.4 ≤ HR ≤ 2.51).

LIMITATIONS

Meta-analysis options were limited by the variety of study designs.

CONCLUSIONS

Evidence for a significant association between familial death and subsequent disorder appears to be an artefact of the study design. Implications of key findings. Further studies are required to better understand and estimate the association between familial death and substance use disorders. Registration and funding. The review was pre-registered (PROSPERO Reg No: CRD42020192892) and funded by the Irish Research Council (COALESCE/2019/61).

摘要

背景

儿童期逆境暴露与成年后患长期负面心理健康后果有关。

目的

本综述研究了儿童期或青少年时期家庭成员(即父母或兄弟姐妹)死亡暴露与随后诊断物质使用障碍之间的关联。

方法

使用电子数据库(Scopus、Medline(Ovid 版)、EMBASE 和 PsychINFO)搜索英语队列和病例对照研究。如果暴露于死亡发生在 18 岁之前,并且随后诊断出障碍,则保留研究。对荟萃分析进行了敏感性分析,并使用纽卡斯尔-渥太华量表评估了研究质量。

结果

保留了九项研究,七项队列研究和两项病例对照研究。由于指标不同(危害比 [HR]与比值比 [OR] /风险比 [RR]),仅进行了一项荟萃分析。与未暴露者相比,经历过家庭死亡的个体发生物质使用障碍的可能性是其 1.42 倍(95%CI=0.96,2.09)。在其他研究中存在统计学意义的效应,这些研究大多使用国家登记处(1.4≤HR≤2.51)。

局限性

元分析选项受到各种研究设计的限制。

结论

家族死亡与随后的障碍之间存在显著关联的证据似乎是研究设计的一个假象。主要发现的意义。需要进一步的研究来更好地理解和估计家族死亡与物质使用障碍之间的关联。注册和资金。该综述已预先注册(PROSPERO 注册号:CRD42020192892),并由爱尔兰研究委员会(COALESCE/2019/61)资助。

相似文献

1
The association between familial death in childhood or adolescence and subsequent substance use disorder: A systematic review and meta-analysis.儿童或青少年时期家族成员死亡与随后物质使用障碍之间的关联:系统评价和荟萃分析。
Addict Behav. 2021 Sep;120:106936. doi: 10.1016/j.addbeh.2021.106936. Epub 2021 Mar 26.
2
Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines.右雷佐生预防或减少接受蒽环类抗生素治疗的癌症成人和儿童的心脏毒性。
Cochrane Database Syst Rev. 2022 Sep 27;9(9):CD014638. doi: 10.1002/14651858.CD014638.pub2.
3
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD010216. doi: 10.1002/14651858.CD010216.pub7.
4
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
5
Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.职业性HIV暴露后的抗逆转录病毒暴露后预防(PEP)。
Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD002835. doi: 10.1002/14651858.CD002835.pub3.
6
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD010216. doi: 10.1002/14651858.CD010216.pub6.
7
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2024 Jan 8;1(1):CD010216. doi: 10.1002/14651858.CD010216.pub8.
8
Electronic cigarettes for smoking cessation.用于戒烟的电子烟。
Cochrane Database Syst Rev. 2025 Jan 29;1(1):CD010216. doi: 10.1002/14651858.CD010216.pub9.
9
Psychological and/or educational interventions for the prevention of depression in children and adolescents.预防儿童和青少年抑郁症的心理和/或教育干预措施。
Cochrane Database Syst Rev. 2004(1):CD003380. doi: 10.1002/14651858.CD003380.pub2.
10
Control interventions in randomised trials among people with mental health disorders.精神障碍患者随机试验中的对照干预措施。
Cochrane Database Syst Rev. 2022 Apr 4;4(4):MR000050. doi: 10.1002/14651858.MR000050.pub2.